HRT · Local vaginal estrogen

Vaginal Estradiol

For the symptoms that nobody talks about — and that don't go away on their own.

Vaginal dryness, painful sex, urinary urgency, recurrent UTIs — these aren't a separate condition. They're genitourinary syndrome of menopause, and they're the predictable result of estrogen falling away from the tissues that depend on it. Local vaginal estradiol — cream or insert — treats it directly, with very little hormone reaching the bloodstream. For many women, this is the most underrated, highest-impact piece of menopause care.

  • Cream or vaginal insert format — chosen by your clinician
  • Local action with minimal systemic absorption
  • Treats vaginal dryness, painful sex, and recurrent UTIs at the source
  • Often appropriate even when systemic HRT isn't
  • FDA-approved formulations · monthly billing
Take the menopause assessment

Why local matters

Different from systemic HRT — different rules apply.

Woman in midlife considering her care options

The vaginal and urinary tissues have a high density of estrogen receptors. After menopause, with systemic estradiol low, those tissues thin, lose elasticity, dry out, and become more susceptible to infection. Roughly half of post-menopausal women experience this — and unlike hot flashes, it doesn't get better on its own. It typically gets worse.

Local vaginal estradiol delivers a small amount of hormone directly to the tissue that needs it. Blood levels stay near the post-menopausal baseline; the local effect on tissue is meaningful. The safety profile is favorable enough that vaginal estradiol is sometimes appropriate even for women with histories that rule out systemic HRT — that's a clinician judgment, but the menopause societies have moved toward more permissive use here than they were a decade ago.

This is one of the highest-leverage interventions in menopause care, and one of the most under-prescribed. If the symptoms are showing up for you, raising it in your assessment is the right move — women routinely report that this single piece changes how their body feels in a way nothing else did.

A loading phase. Then twice weekly.

1
Loading phase
Most regimens start with a daily application or insert for 2 weeks. This is the “loading” phase that re-establishes the tissue's baseline.
2
Maintenance
After loading, most women shift to twice-weekly dosing for ongoing maintenance. The schedule is forgiving — missed doses don't undo the work, you just resume.
3
Stay on it
This isn't a course of treatment with an end date. Continuing the maintenance keeps the tissue where you want it. If you stop, the tissue typically reverts within months. Your clinician will discuss long-term planning.

Side effects & safety

What to know before you start.

Woman reviewing health information at home

Most common: mild local irritation in the first week, occasional discharge, brief itching during the loading phase. These are typically transient.

Less common but worth flagging: spotting (especially during loading — usually settles, but report any persistent bleeding), recurrent yeast or bacterial infections (sometimes a sign of tissue still adjusting), allergic reaction to the vehicle.

Compared to systemic HRT: the safety profile of low-dose vaginal estradiol is meaningfully different. Systemic absorption is minimal, and current menopause society guidance is that vaginal estrogen is often appropriate even for women whose history rules out systemic HRT — though the decision is individual and your clinician makes it.

Not appropriate without clinician review if: you have a personal history of certain hormone-sensitive cancers, unexplained vaginal bleeding, or active genital infection. Your assessment surfaces these factors carefully.

Prescription medication notice
Vaginal estradiol formulations (creams, tablets, inserts, rings) are FDA-approved prescription medications. Treatment is initiated and monitored by an independent licensed clinician based on your assessment and ongoing response.

Questions

Answers to
common questions.

Can I use this if I can't take systemic HRT?
Often yes — the safety profile is genuinely different. Your clinician decides.
Often yes — current menopause society guidance recognizes that low-dose vaginal estrogen has minimal systemic absorption and a meaningfully different safety profile than systemic HRT. Many women whose history rules out systemic HRT are still appropriate candidates for vaginal estradiol. That's a clinician judgment based on your specific picture, not a blanket answer — but the door is open more often than people assume.
Cream vs. insert — how does my clinician decide?
Mostly: which one you'll actually use consistently.
The two formats deliver similar local effects. Cream is more flexible (you can apply it to specific areas including the vulva), some women find it messier. Inserts are tidier and more discrete but only deliver into the vagina itself. Your clinician asks about preference; the right answer is the one you'll keep doing.
When am I charged?
Not until a clinician confirms your eligibility.
You're not charged when you submit. Your card is saved. A licensed clinician reviews your assessment, typically within 24 hours. If approved and you accept the recommended regimen, you'll be notified by email before the first charge.
Can I cancel?
Yes — anytime, with no contract.
Yes. Menopause care is monthly with no committed term. Cancel future shipments anytime through your account.

Find out if vaginal estradiol belongs in your regimen.

The 3-minute symptoms assessment is free. Your clinician follows up within 24 hours with a personalized recommendation.

Take the menopause assessment